| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.20B | 23.77B | 21.50B | 19.41B | 17.61B | 15.79B |
| Gross Profit | 22.46B | 21.06B | 19.15B | 17.05B | 15.44B | 13.92B |
| EBITDA | 9.75B | 9.75B | 7.96B | 7.78B | 7.05B | 6.67B |
| Net Income | 7.23B | 7.13B | 5.56B | 5.43B | 4.76B | 4.82B |
Balance Sheet | ||||||
| Total Assets | 29.93B | 29.50B | 30.23B | 29.78B | 27.16B | 27.24B |
| Cash, Cash Equivalents and Short-Term Investments | 5.63B | 6.59B | 7.89B | 7.84B | 6.10B | 5.80B |
| Total Debt | 7.07B | 6.65B | 6.06B | 4.08B | 4.63B | 4.67B |
| Total Liabilities | 18.41B | 17.87B | 16.13B | 13.26B | 13.11B | 12.44B |
| Stockholders Equity | 11.52B | 11.62B | 14.11B | 16.52B | 14.05B | 14.80B |
Cash Flow | ||||||
| Free Cash Flow | 10.28B | 9.85B | 7.82B | 6.94B | 7.40B | 6.89B |
| Operating Cash Flow | 10.48B | 10.03B | 8.06B | 7.30B | 7.84B | 7.22B |
| Investing Cash Flow | -1.67B | -1.19B | 149.00M | 776.00M | -570.00M | -3.54B |
| Financing Cash Flow | -8.83B | -11.06B | -7.72B | -5.18B | -6.83B | -4.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $2.90T | 23.17 | 33.13% | 0.44% | 17.87% | 29.63% | |
76 Outperform | $82.46B | 11.35 | 62.31% | ― | 11.49% | 11.45% | |
72 Outperform | $86.91B | 111.86 | 2.64% | ― | 39.60% | -69.00% | |
71 Outperform | $41.87B | 28.62 | 49.42% | ― | 18.88% | 46.42% | |
64 Neutral | $11.89B | -17.60 | -21.33% | ― | 7.55% | -39.50% | |
62 Neutral | $9.80B | -6.62 | -101.33% | ― | 41.42% | -88.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |